Similar articles for PMID: 30076245

Year	Number of Results
1977	3
1983	1
1994	1
2002	1
2005	2
2006	4
2007	1
2008	1
2009	2
2010	3
2011	8
2012	12
2013	19
2014	13
2015	25
2016	22
2017	31
2018	42
2019	39
2020	47
2021	35
2022	32
2023	26
2024	23
2025	1

1

Guidance on ¹⁷⁷Lu-DOTATATE Peptide Receptor Radionuclide Therapy from the Experience of a Single Nuclear Medicine Division.

Abbott A, Sakellis CG, Andersen E, Kuzuhara Y, Gilbert L, Boyle K, Kulke MH, Chan JA, Jacene HA, Van den Abbeele AD. Abbott A, et al. J Nucl Med Technol. 2018 Sep;46(3):237-244. doi: 10.2967/jnmt.118.209148. Epub 2018 Aug 3. J Nucl Med Technol. 2018. PMID: 30076245 Free article.

2

Performance of 177Lu-DOTATATE-based peptide receptor radionuclide therapy in metastatic gastroenteropancreatic neuroendocrine tumor: a multiparametric response evaluation correlating with primary tumor site, tumor proliferation index, and dual tracer imaging characteristics.

Thapa P, Ranade R, Ostwal V, Shrikhande SV, Goel M, Basu S. Thapa P, et al. Nucl Med Commun. 2016 Oct;37(10):1030-7. doi: 10.1097/MNM.0000000000000547. Nucl Med Commun. 2016. PMID: 27243215

3

Persistent Hematologic Dysfunction after Peptide Receptor Radionuclide Therapy with ¹⁷⁷Lu-DOTATATE: Incidence, Course, and Predicting Factors in Patients with Gastroenteropancreatic Neuroendocrine Tumors.

Bergsma H, van Lom K, Raaijmakers MHGP, Konijnenberg M, Kam BLBLR, Teunissen JJM, de Herder WW, Krenning EP, Kwekkeboom DJ. Bergsma H, et al. J Nucl Med. 2018 Mar;59(3):452-458. doi: 10.2967/jnumed.117.189712. Epub 2017 Aug 3. J Nucl Med. 2018. PMID: 28775205 Free article.

4

How We Do It: A Multidisciplinary Approach to ¹⁷⁷Lu DOTATATE Peptide Receptor Radionuclide Therapy.

Burkett BJ, Dundar A, Young JR, Packard AT, Johnson GB, Halfdanarson TR, Eiring RA, Gansen DN, Patton CM, Kendi AT. Burkett BJ, et al. Radiology. 2021 Feb;298(2):261-274. doi: 10.1148/radiol.2020201745. Epub 2020 Nov 24. Radiology. 2021. PMID: 33231532

5

Resistant functioning and/or progressive symptomatic metastatic gastroenteropancreatic neuroendocrine tumors: efficacy of 177Lu-DOTATATE peptide receptor radionuclide therapy in this setting.

Kalshetty A, Ramaswamy A, Ostwal V, Basu S. Kalshetty A, et al. Nucl Med Commun. 2018 Dec;39(12):1143-1149. doi: 10.1097/MNM.0000000000000926. Nucl Med Commun. 2018. PMID: 30308585

6

Peptide receptor radionuclide therapy for patients with advanced pancreatic neuroendocrine tumors.

Ramage J, Naraev BG, Halfdanarson TR. Ramage J, et al. Semin Oncol. 2018 Aug;45(4):236-248. doi: 10.1053/j.seminoncol.2018.08.004. Epub 2018 Oct 24. Semin Oncol. 2018. PMID: 30539715 Free article. Review.

7

Long-Term Efficacy, Survival, and Safety of [¹⁷⁷Lu-DOTA⁰,Tyr³]octreotate in Patients with Gastroenteropancreatic and Bronchial Neuroendocrine Tumors.

Brabander T, van der Zwan WA, Teunissen JJM, Kam BLR, Feelders RA, de Herder WW, van Eijck CHJ, Franssen GJH, Krenning EP, Kwekkeboom DJ. Brabander T, et al. Clin Cancer Res. 2017 Aug 15;23(16):4617-4624. doi: 10.1158/1078-0432.CCR-16-2743. Epub 2017 Apr 20. Clin Cancer Res. 2017. PMID: 28428192

8

Surgical Feasibility, Determinants, and Overall Efficacy of Neoadjuvant ¹⁷⁷Lu-DOTATATE PRRT for Locally Advanced Unresectable Gastroenteropancreatic Neuroendocrine Tumors.

Parghane RV, Bhandare M, Chaudhari V, Ostwal V, Ramaswamy A, Talole S, Shrikhande SV, Basu S. Parghane RV, et al. J Nucl Med. 2021 Nov;62(11):1558-1563. doi: 10.2967/jnumed.120.258772. Epub 2021 Feb 26. J Nucl Med. 2021. PMID: 33637590 Free PMC article.

9

Peptide receptor radionuclide therapy (PRRT) for GEP-NETs.

Bergsma H, van Vliet EI, Teunissen JJ, Kam BL, de Herder WW, Peeters RP, Krenning EP, Kwekkeboom DJ. Bergsma H, et al. Best Pract Res Clin Gastroenterol. 2012 Dec;26(6):867-81. doi: 10.1016/j.bpg.2013.01.004. Best Pract Res Clin Gastroenterol. 2012. PMID: 23582925

10

¹⁷⁷Lu-DOTATATE for the treatment of gastroenteropancreatic neuroendocrine tumors.

Das S, Al-Toubah T, El-Haddad G, Strosberg J. Das S, et al. Expert Rev Gastroenterol Hepatol. 2019 Nov;13(11):1023-1031. doi: 10.1080/17474124.2019.1685381. Epub 2019 Oct 30. Expert Rev Gastroenterol Hepatol. 2019. PMID: 31652074 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

353 results

Results by year

Filters

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Similar articles for PMID: 30076245

353 results

Results by year